Skip to main content

4 Result(s)

within Chapter Remove this filter S. Biancoli Remove this filter

and

  1. No Access

    Chapter and Conference Paper

    Warfarin Underuse for Nonvalvular Atrial Fibrillation: How to Adjust Our Aims?

    Atrial fibrillation (AF) is the most common arrhythmia in clinical practice; its prevalence increases substantially with age, representing a growing epidemic with substantial effects on mortality and morbidity...

    G. Di Pasquale, E. Ceré, A. Lombardi, B. Sassone, S. Biancoli… in Cardiac Arrhythmias 2003 (2004)

  2. No Access

    Chapter and Conference Paper

    Anticoagulation Therapy of Atrial Fibrillation in the Elderly

    The prevalence of atrial fibrillation (AF) increases substantially with age. The most recent data come from a cross-sectional study of adults in California, dealing with a population of 1.89 million [1]. The over...

    G. Di Pasquale, E. Cerè, A. Lombardi… in New Advances in Heart Failure and Atrial F… (2003)

  3. No Access

    Chapter and Conference Paper

    Antiplatelet Agents for Prevention of Thromboembolism in Atrial Fibrillation: When, Why, and Which One?

    Atrial fibrillation (AF) carries a high risk of systemic embolism, in particular stroke. This is true not only when AF is associated with valvular heart disease, but also in patients with nonvalvular AF, which...

    G. Di Pasquale, E. Cerè, S. Biancoli, B. Sassone, A. Lombardi… in Cardiac Arrhythmias 2001 (2002)

  4. No Access

    Chapter

    Prevention of Thromboembolism in Atrial Fibrillation: When Antiplatelet Agents and When Anticoagulants?

    Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia encountered in clinical practice.

    G. Di Pasquale, G. Pinelli, S. Urbinati, S. Biancoli… in Cardiac Arrhythmias 1997 (1998)